CHKD announced it is suspending hormone therapy and puberty blockers for gender-affirming care in children under age 19, in accordance with President Trump's executive order.
Sep. 4, 2024 — A treatment paradox has recently come to light in prostate cancer: blocking testosterone production halts tumor growth in early disease, while elevating the hormone can delay ...